Steven R. Hagen, SVP Pharmaceutical Development & Mfg at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 10,797 shares at $18.99 ($205K) on 2014-08-08, disclosed to the SEC on 2014-08-12.
Open-market sale of $205k AMRI by SVP Pharmaceutical Development & Mfg. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.99 | 797 | $15K | 7.4% |
| 2 | $18.99 | 10,000 | $190K | 92.6% |
| Total | $18.99 avg | 10,797 | $205K | 100% |
| Filing → |
| AMRI | SELL | 2016-08-10 | $21K | — | Filing → |
| AMRI | SELL | 2016-05-16 | $30K | — | Filing → |
| AMRI | SELL | 2015-08-17 | $20K | — | Filing → |